Compound library / Topical / Skincare

Argireline (Acetyl Hexapeptide-8)

Cosmetic peptide marketed as a "topical Botox alternative" that may modestly soften expression lines by relaxing facial muscle contraction signals — effects are far subtler than injectable neuromodulators.

CategoryTopical / Skincare
Regulatory standingNo approved product cited
Typical routeTopical
Half-lifeN/A — topical, minimal systemic absorption
Common dose rangeThin layer to targeted areas (e.g. forehead, crow's feet), once or twice daily
Typical cycle lengthOngoing — visible results, where present, typically take 4-8 weeks

BioHack Track models Argireline (Acetyl Hexapeptide-8) at a half-life of 4 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

No approved product cited

No FDA-approved product for this compound is cited on this page, and no approved human dose is quoted. Treat the range below as research and community practice rather than a prescribed dose.

Reconstitution

Topical serum/cream; no reconstitution needed.

Storage

Store at room temperature, away from direct light.

Cautions

Generally well tolerated; evidence for visible effect is mixed/modest compared to injectable alternatives — manage expectations.

Track Argireline (Acetyl Hexapeptide-8) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Topical / Skincare

Look up the research

These open a search of each database for Argireline (Acetyl Hexapeptide-8) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Where these figures come from

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support